Trial intelligence / Profile preview

Remimazolam vs propofol for laryngeal mask airway anesthesia in daytime surgery

ChiCTR2000037276Phase 4Recruiting

Sponsor
Hunan Provincial People's Hospital
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam (2 arms), sponsored by Hunan Provincial People's Hospital. Primary endpoints: Hemodynamics, Laryngeal mask insertion condition and 2 more. Started Aug 2020; status: recruiting.

02

Drugs

remimazolam

Beyond the preview

Go deeper on ChiCTR2000037276.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000037276.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call